You should change your name from J.L. to Splinter, all you do is...

First 8 Last

Share
Profile

Follow
Isildurrr

100 Posts.

25

18/11/21

06:55

Post #: 57658068
Share

Originally posted by J L: ↑

Isildurr, thank you for your comment. If it makes you feel good to have a shot at the bad boy, well and good. But, I will treat your comment with a degree of respect.

Look at what you have:

An abundance of probably the cheapest feedstock on the planet.

Proven technology in the urea plant.

A ready market.

Capable of competing favourably anywhere in the world.

As I see it, you have only two hurdles, finance and environmental.

But what do you do. You and your mates sit around around indulging in useless rhetoric, which has very little value.

Yes, I do follow the money trail and share dilution very closely.

If things don't pan out as you hope they will, you could end up with a $3 billion company with a share say, 15 cents,

The Investor is sitting on $12 million which LCK will probably need very soon. So why don't you do something useful. Study the Agreement and see how badly it favours LCK. Make some useful comment on how funding might be delivered in the next couple of years.

This also includes maybe a massive share placement, and its effect on Board composition, dilution, and share price.

Let's work together to better understand the financial implications going forward. J L.

Expand

You should change your name from J.L. to Splinter, all you do is sit on the fence. Each way bet ay Splinter.

LCK Price at posting: 13.5¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

PL3

Patagonia looks to raise $2.15M for South American exploration and development

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

There are more pages in this discussion • 8 more messages in this thread...

First 8 Last

Add NRZ (ASX) to my watchlist

(20min delay)
Last 1.1¢		Change 0.001(10.0%)		Mkt cap ! $20.92M

Open	High	Low	Value	Volume
1.0¢	1.3¢	0.9¢	$112.0K	9.997M

Buyers (Bids)

No.	Vol.	Price($)
2	206728	1.1¢

Sellers (Offers)

Price($)	Vol.	No.
1.2¢	85000	1

View Market Depth

No.	Vol.	Price($)
2	206728	0.011
7	2400500	0.010
5	990000	0.009
3	375611	0.008
3	3253968	0.007

Price($)	Vol.	No.
0.012	85000	1
0.013	10000	1
0.016	1529164	5
0.017	212562	3
0.020	200000	1

Last trade - 16.10pm 09/07/2024 (20 minute delay)

NRZ (ASX) Chart

You should change your name from J.L. to Splinter, all you do is...

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Patagonia looks to raise $2.15M for South American exploration and development

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

You should change your name from J.L. to Splinter, all you do is...

Top Stories

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Patagonia looks to raise $2.15M for South American exploration and development

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News